This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Oct 17;163(8):956-7.

Anticoagulation therapy for patients with atrial fibrillation

R G Hart

PMID: 11068566
PMCID: PMC80541

Comment

Anticoagulation therapy for patients with atrial fibrillation

R G Hart. CMAJ. 2000.

. 2000 Oct 17;163(8):956-7.

Author

R G Hart

PMID: 11068566
PMCID: PMC80541

No abstract available

PubMed Disclaimer

Comment in

Anticoagulation therapy for patients with atrial fibrillation.
Connolly SJ. Connolly SJ. CMAJ. 2000 Nov 14;163(10):1235. CMAJ. 2000. PMID: 11186669 Free PMC article. No abstract available.

Comment on

Preventing stroke in atrial fibrillation: why are so many eligible patients not receiving anticoagulant therapy?
Connolly SJ. Connolly SJ. CMAJ. 1999 Sep 7;161(5):533-4. CMAJ. 1999. PMID: 10497611 Free PMC article. No abstract available.

Similar articles

Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW. Mant JW. Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344. Thromb Haemost. 2008. PMID: 18612531 No abstract available.
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM. Hylek EM. Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343. Thromb Haemost. 2008. PMID: 18612532 No abstract available.
Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
Burkiewicz JS. Burkiewicz JS. Pharmacotherapy. 2005 Aug;25(8):1062-7. doi: 10.1592/phco.2005.25.8.1062. Pharmacotherapy. 2005. PMID: 16207096
Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.
Wittkowsky AK. Wittkowsky AK. Am J Manag Care. 2004 Oct;10(10 Suppl):S297-306; discussion S312-7. Am J Manag Care. 2004. PMID: 15605700 Review.
Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
Hammwöhner M, Goette A. Hammwöhner M, et al. J Cardiovasc Pharmacol. 2008 Jul;52(1):18-27. doi: 10.1097/FJC.0b013e318177e1f2. J Cardiovasc Pharmacol. 2008. PMID: 18594479 Review.

See all similar articles

Cited by

Anticoagulation therapy for patients with atrial fibrillation.
Connolly SJ. Connolly SJ. CMAJ. 2000 Nov 14;163(10):1235. CMAJ. 2000. PMID: 11186669 Free PMC article. No abstract available.
Patients' perspectives on taking warfarin: qualitative study in family practice.
Dantas GC, Thompson BV, Manson JA, Tracy CS, Upshur RE. Dantas GC, et al. BMC Fam Pract. 2004 Jul 21;5:15. doi: 10.1186/1471-2296-5-15. BMC Fam Pract. 2004. PMID: 15268764 Free PMC article.

References

1. Connolly SJ. Preventing stroke in atrial fibrillation: Why are so many eligible patients not receiving anticoagulant therapy? CMAJ 1999;161(5):533-4. - PMC - PubMed
1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154: 1449-57. - PubMed
1. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation. A meta-analysis. Ann Intern Med 1999;131:492-501. - PubMed
1. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspiring therapy in atrial fibrillation. Stroke 1999;30:1223-9. - PubMed
1. Perez I, Melboun A, Kalra L. Aprpopriateness of antithrombotic measures for stroke prevention in atrial fibrillation. Heart 1999;82:570-4. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information